Skip to Main Content


Skip Nav Destination

Abstract CT128: Palbociclib in combination with fulvestrant or tamoxifen as treatment for hormone receptor positive metastatic breast cancer with prior chemotherapy for advanced disease (TBCRC 035): A Phase II study with pharmacodynamic markers

Cancer Res (2019) 79 (13_Supplement): CT128.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Komal Jhaveri
  • Howard A Burris 3rd
  • Timothy A Yap
  • Erika Hamilton
  • Hope S Rugo
  • Jonathan W Goldman
  • Stephen Dann
  • Feng Liu
  • Gilbert Y Wong
  • Heike Krupka
  • Geoffrey I Shapiro
Expert Review of Anticancer Therapy (2021) 21 (10): 1105.
Close Modal

or Create an Account

Close Modal
Close Modal